Other OTC - Delayed Quote USD

Hamilton Thorne Ltd. (HTLZF)

1.0200 0.0000 (0.00%)
At close: May 13 at 3:49 PM EDT
Loading Chart for HTLZF
DELL
  • Previous Close 1.0200
  • Open 1.0050
  • Bid --
  • Ask --
  • Day's Range 1.0200 - 1.0200
  • 52 Week Range 0.8030 - 1.2300
  • Volume 3,792
  • Avg. Volume 5,459
  • Market Cap (intraday) 155.813M
  • Beta (5Y Monthly) 0.28
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Aug 15, 2024 - Aug 19, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, the company manufactures and distributes medical products for reproductive medicine; manufactures bespoke workstations, incubators, and equipment for IVF laboratories; researches, designs, develops, sells, installs, and services in-vitro diagnostic systems; and manufactures ovum pickup needles, catheters, and other devices. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as capital equipment and consumables, software, and other services. It sells its products and services under Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech brand names through a direct sales force in the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 100 countries. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.

www.hamiltonthorne.ltd

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HTLZF

Performance Overview: HTLZF

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HTLZF
0.99%
S&P/TSX Composite index
6.33%

1-Year Return

HTLZF
15.00%
S&P/TSX Composite index
9.13%

3-Year Return

HTLZF
34.11%
S&P/TSX Composite index
15.07%

5-Year Return

HTLZF
17.92%
S&P/TSX Composite index
36.85%

Compare To: HTLZF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HTLZF

Valuation Measures

Annual
As of 5/14/2024
  • Market Cap

    156.48M

  • Enterprise Value

    174.70M

  • Trailing P/E

    --

  • Forward P/E

    34.01

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.24

  • Price/Book (mrq)

    2.41

  • Enterprise Value/Revenue

    2.60

  • Enterprise Value/EBITDA

    31.64

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.90%

  • Return on Assets (ttm)

    0.46%

  • Return on Equity (ttm)

    -1.00%

  • Revenue (ttm)

    67.23M

  • Net Income Avi to Common (ttm)

    -607.02k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.73M

  • Total Debt/Equity (mrq)

    43.24%

  • Levered Free Cash Flow (ttm)

    111.78k

Research Analysis: HTLZF

Company Insights: HTLZF

Research Reports: HTLZF

People Also Watch